Inventor
Rolf Baenteli
Inventor
Basel, CH
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes17%
Y02PClimate change mitigation technologies in the production or processing of goods11%
C07CAcyclic or carbocyclic compounds6%
PatentTitleYear
8,431,589'2,4-diaminopyrimidine derivatives'20138,283,356'2,4- Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitors'20127,943,627'2,4-diaminopyrimidine derivatives'20117,671,063'2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors'20107,666,877'Ergoline derivatives'20106,818,638'Melvinolin derivatives'2004Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2004–2013Patents assigned to NOVARTIS AG (6)· patent assignee history
2004–2013Based in Basel, CH· patent location history
2012–2013Patents assigned to BAENTELI ROLF (2)· patent assignee history
2012–2013Patents assigned to COOKE NIGEL GRAHAM (2)· patent assignee history
2012–2013Patents assigned to DUTHALER RUDOLF (2)· patent assignee history
2012–2013Patents assigned to HINTERDING KLAUS (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 6 | 2004–2013 |
| BAENTELI ROLFself | 2 | 2012–2013 |
| COOKE NIGEL GRAHAM | 2 | 2012–2013 |
| DUTHALER RUDOLF | 2 | 2012–2013 |
| HINTERDING KLAUS | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Basel, CH | 6 | 2004–2013 |